Key facts
- This page summarizes Anthony M. Manning's Form 4 filing for Monte Rosa Therapeutics, Inc. (GLUE).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 May 2026, 16:05.
Anthony M. Manning - 21 May 2026 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)
- Reporting relationship
- Director
- Issuer ticker
- GLUE
- Reported as of
- 21 May 2026
- Net transaction value
- -$180,100
- SEC form
- 4
- Accepted by SEC
- 22 May 2026, 16:05:09 UTC
- Prior SEC filing
- 16 Jun 2025
- Next SEC filing
- 12 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Markus Warmuth, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Anthony M. Manning filed Form 4 for Monte Rosa Therapeutics, Inc. (GLUE) on 22 May 2026.
Change
- Previous filing in this sequence was filed on 16 Jun 2025.
- Current net transaction value: -$180,100.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001716468
Primary reporting owner
Manning Anthony M.
- Relationship
- Director
- Address
- MONTE ROSA THERAPEUTICS, INC., 321 HARRISON AVENUE, SUITE 900, BOSTON
- Signature
- /s/ Markus Warmuth, Attorney-in-Fact
- Signature date
- 22 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GLUE
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +10,000
- Change %
- Price
- $4.16*
- Shares after
- 10,000
- Date
- 21 May 2026
- Ownership
- Direct
GLUE
transaction
Common Stock
Sale
- Transaction value
- $180,100
- Shares
- -10,000
- Change %
- -100%
- Price
- $18.01
- Shares after
- 0
- Date
- 21 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GLUE
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -10,000
- Change %
- -45%
- Price
- $0.000000*
- Shares after
- 12,100
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $4.16
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares subject to this option are fully vested and exercisable.